BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1397059)

  • 1. Serotonin inhibits adenylate cyclase in human platelet membranes.
    Newman ME
    Eur J Pharmacol; 1992 Aug; 226(4):281-5. PubMed ID: 1397059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
    Bouhelal R; Smounya L; Bockaert J
    Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin inhibition of adenylate cyclase in human platelet membranes; relation to 5-HT-1A receptor-mediated activity.
    Newman ME
    Biochem Pharmacol; 1994 Nov; 48(9):1677-82. PubMed ID: 7980635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists.
    Devivo M; Maayani S
    Eur J Pharmacol; 1985 Dec; 119(3):231-4. PubMed ID: 2936612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.
    De Vivo M; Maayani S
    Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
    Schoeffter P; Hoyer D
    Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.
    Schoeffter P; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):285-92. PubMed ID: 2572975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
    Pauwels PJ; Palmier C
    Neuropharmacology; 1994 Jan; 33(1):67-75. PubMed ID: 7910388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
    De Vivo M; Maayani S
    J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
    Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.
    Schoeffter P; Waeber C; Palacios JM; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):602-8. PubMed ID: 3216894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.
    Adham N; Kao HT; Schecter LE; Bard J; Olsen M; Urquhart D; Durkin M; Hartig PR; Weinshank RL; Branchek TA
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):408-12. PubMed ID: 8380639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
    Giles H; Lansdell SJ; Bolofo ML; Wilson HL; Martin GR
    Br J Pharmacol; 1996 Mar; 117(6):1119-26. PubMed ID: 8882605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling of the platelet alpha 2-adrenoceptor adenylate cyclase system by N-ethylmaleimide and the resulting effect on receptor density and sensitivity.
    GarcĂ­a-Sevilla JA; Areso P; Giralt MT; Ulibarri I
    Eur J Pharmacol; 1988 Jan; 145(1):91-5. PubMed ID: 2832185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists".
    Toohey N; Klein MT; Knight J; Smith C; Teitler M
    Mol Pharmacol; 2009 Sep; 76(3):552-9. PubMed ID: 19509219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-1C sites in the choroid plexus are not linked in a stimulatory or inhibitory way to adenylate cyclase.
    Palacios JM; Markstein R; Pazos A
    Brain Res; 1986 Aug; 380(1):151-4. PubMed ID: 3019464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.